BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8377957)

  • 21. Methotrexate in the treatment of steroid-dependent asthma.
    Dyer PD; Vaughan TR; Weber RW
    J Allergy Clin Immunol; 1991 Aug; 88(2):208-12. PubMed ID: 1880321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of methotrexate for treatment of corticosteroid-dependent asthma].
    Kazimierczak A; Maziarka D; Skorupa W; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):225-30. PubMed ID: 9489419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study.
    Erzurum SC; Leff JA; Cochran JE; Ackerson LM; Szefler SJ; Martin RJ; Cott GR
    Ann Intern Med; 1991 Mar; 114(5):353-60. PubMed ID: 1992876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial.
    Bernstein IL; Bernstein DI; Dubb JW; Faiferman I; Wallin B
    J Allergy Clin Immunol; 1996 Aug; 98(2):317-24. PubMed ID: 8757209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate in the treatment of corticodependent asthmatic children.
    Solé D; Costa-Carvalho BT; Soares FJ; Rullo VV; Naspitz CK
    J Investig Allergol Clin Immunol; 1996; 6(2):126-30. PubMed ID: 8727271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma.
    Shiner RJ; Nunn AJ; Chung KF; Geddes DM
    Lancet; 1990 Jul; 336(8708):137-40. PubMed ID: 1973472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of methotrexate in the management of steroid-dependent asthma.
    Coffey MJ; Sanders G; Eschenbacher WL; Tsien A; Ramesh S; Weber RW; Toews GB; McCune WJ
    Chest; 1994 Jan; 105(1):117-21. PubMed ID: 7903921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of oral pulse methotrexate with placebo in the treatment of severe glucocorticosteroid-dependent asthma.
    Stewart GE; Diaz JD; Lockey RF; Seleznick MJ; Trudeau WL; Ledford DK
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):482-9. PubMed ID: 8083453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of steroid-dependent asthma with methotrexate: a meta-analysis of randomized clinical trials.
    Aaron SD; Dales RE; Pham B
    Respir Med; 1998 Aug; 92(8):1059-65. PubMed ID: 9893776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose methotrexate spares steroid usage in steroid-dependent asthmatic patients: a meta-analysis.
    Marin MG
    Chest; 1997 Jul; 112(1):29-33. PubMed ID: 9228353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of methotrexate 30 mg per week with placebo in chronic steroid-dependent asthma: a 12-week double-blind, cross-over study.
    Trigg CJ; Davies RJ
    Respir Med; 1993 Apr; 87(3):211-6. PubMed ID: 8497701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.
    Baughman RP; Winget DB; Lower EE
    Sarcoidosis Vasc Diffuse Lung Dis; 2000 Mar; 17(1):60-6. PubMed ID: 10746262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of steroid-dependent bronchial asthma with cyclosporin.
    Nizankowska E; Soja J; Pinis G; Bochenek G; Sładek K; Domagała B; Pajak A; Szczeklik A
    Eur Respir J; 1995 Jul; 8(7):1091-9. PubMed ID: 7589392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant and corticosteroid-dependent idiopathic anaphylaxis: successful responses to ketotifen.
    Patterson R; Fitzsimons EJ; Choy AC; Harris KE
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):138-44. PubMed ID: 9291418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steroids and "steroid-sparing" agents in asthma.
    N Engl J Med; 1988 Sep; 319(10):650-2. PubMed ID: 3045548
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term methotrexate treatment in corticosteroid-dependent asthma.
    Mullarkey MF; Lammert JK; Blumenstein BA
    Ann Intern Med; 1990 Apr; 112(8):577-81. PubMed ID: 2327677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long term and low dose treatment with methotrexate in corticosteroid-dependent asthma--two-year clinical experience].
    Liang TW; Tsai JJ; Wang SR
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):264-9. PubMed ID: 1342643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weekly low-dose methotrexate for reduction of Global Initiative for Asthma Step 5 treatment in severe refractory asthma: study protocol for a randomized controlled trial.
    Polosa R; Bellinvia S; Caruso M; Emma R; Alamo A; Kowalski ML; Domingo C
    Trials; 2014 Dec; 15():492. PubMed ID: 25523634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
    Bilocca D; Hargadon B; Pavord ID; Green RH; Brightling CE; Bradding P; Wardlaw AJ; Martin N; Murphy AC; Siddiqui S
    Chron Respir Dis; 2018 Feb; 15(1):85-87. PubMed ID: 28569072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose methotrexate in the management of Chinese patients with steroid-dependent asthma.
    Yew WW; Lee J; Wong PC; Wong CF; Chau CH
    Drugs Exp Clin Res; 1996; 22(6):317-21. PubMed ID: 9034758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.